Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials - NUS Enterprise

Skip to content

Start-Up Stories
News
Events
Funding
Contact Us

About Us
- About Us Menu
  About NUS Enterprise
  
  Our People
Education Programmes
Supporting Entrepreneurs
Partnering Corporates
- Corporate Partnerships
  Corporate Partnerships
  Friends of NUS Enterprise
  Accelerators & Challenges
  
  PIER71
  
  ICE71
  
  InnovFest
Research and Resources
- Research and Resources Menu
  Research Projects
  Research Publications
  TechASEAN
  
  Newsletter
  Videos
  NUS Innovation and Venture Creation (IVC) Awards
Technology to Innovation

/ News / By Joanne Ong

Homepage
News
Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials

Homepage
News
Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials

NUS Enterprise

21, Heng Mui Keng Terrace
Level 5
Singapore 119613
+65 6516 7175
enterprise@nus.edu.sg

© National University of Singapore. All Rights Reserved.

Legal
Branding guidelines
Contact Us